Image Guided Radiation Therapy Market: Advancing Precision Cancer Treatment Through AI, Imaging, and Adaptive Radiotherapy

The global Image Guided Radiation Therapy Market is expanding as healthcare providers increasingly adopt advanced technologies that improve the precision, safety, and effectiveness of cancer treatment. Image-guided radiation therapy (IGRT) combines medical imaging with radiation delivery systems to help clinicians accurately locate tumors, monitor changes in tumor position, and adjust treatment delivery during therapy.

According to Kings Research, the global image guided radiation therapy market was valued at USD 2,210.0 million in 2024 and is projected to grow from USD 2,368.3 million in 2025 to USD 4,085.3 million by 2032, registering a CAGR of 8.10% from 2025 to 2032.

The increasing incidence of cancer, advances in medical imaging, development of MRI-guided radiotherapy, and growing adoption of personalized treatment approaches are supporting market growth. IGRT allows radiation oncologists to improve tumor targeting while limiting unnecessary exposure to surrounding healthy tissues.

The technology is particularly valuable for tumors located near sensitive organs or in areas affected by movement, such as the lungs and abdomen. As oncology treatment becomes increasingly precise and personalized, IGRT is becoming an important part of modern radiation therapy infrastructure.

Rising Cancer Incidence Drives Demand for Precision Treatment

The increasing global burden of cancer is one of the strongest factors supporting the Image Guided Radiation Therapy Market. According to the World Health Organization, approximately 20 million new cancer cases were estimated globally in 2022, with annual cases projected to increase substantially by 2050.

The growing patient population is creating greater demand for effective treatment options that can improve clinical outcomes while minimizing treatment-related side effects.

Traditional radiation therapy relies on accurate treatment planning, but tumors can change position because of patient movement, breathing, organ motion, or changes in anatomy during a treatment course. IGRT addresses these challenges by using imaging technologies before or during radiation delivery.

Technologies such as cone-beam computed tomography (CBCT), CT, MRI, and other imaging systems allow clinicians to visualize tumor location and patient anatomy more accurately. This enables treatment teams to make positioning or treatment adjustments when necessary.

As oncology centers increasingly focus on precision medicine, the ability to deliver radiation accurately to the intended target is expected to remain a major driver of IGRT adoption.

Advancements in Imaging-Integrated Radiotherapy

Technological advancements in imaging-integrated radiotherapy are transforming the treatment environment. Modern radiation therapy systems increasingly combine imaging and radiation delivery within integrated platforms.

The use of CT, four-dimensional radiation therapy, MRI-guided systems, and cone-beam CT allows clinicians to obtain detailed information about tumor position, shape, and movement. This information can then be incorporated into treatment planning and radiation delivery.

MRI-guided radiation therapy is particularly promising because MRI can provide high-quality soft-tissue visualization without using ionizing radiation for imaging. This can help clinicians monitor tumors and surrounding structures during treatment.

In July 2024, Kauno klinikos installed an MRI-LINAC system, combining MRI imaging with radiation delivery to support adaptive radiotherapy. The system enables real-time visualization and treatment adjustments designed to improve targeting precision and reduce unnecessary radiation exposure.

Such developments demonstrate how imaging and radiation delivery are becoming increasingly integrated within oncology workflows.

AI-Enhanced MRI-Guided Radiotherapy Emerges as a Major Trend

Artificial intelligence is becoming an increasingly important technology within the Image Guided Radiation Therapy Market. AI can analyze medical images, identify anatomical structures, track tumor movement, and support treatment planning.

The integration of AI with MRI-guided linear accelerators is particularly significant. Tumors in areas affected by breathing or other physiological movements can shift during treatment, making accurate targeting more difficult.

AI algorithms can help track these changes and support adaptive radiation delivery. This may allow treatment teams to respond more efficiently to anatomical changes while maintaining appropriate radiation doses.

Kings Research identifies AI-enhanced MRI-guided radiotherapy as a major market trend. In May 2024, Elekta launched its Elekta Evo CT-Linac at ESTRO 2024, featuring AI-enhanced imaging and capabilities supporting online and offline adaptive radiation therapy.

As AI algorithms become more sophisticated, their use in image segmentation, treatment planning, motion management, and workflow automation is expected to increase.

Radiation Delivery Systems Remain a Core Market Segment

By product type, the market is divided into radiation delivery systems, imaging systems, positioning and motion management devices, software solutions, and services.

Radiation delivery systems generated USD 1,019.7 million in revenue in 2024, making them the leading product segment. Kings Research projects this segment to reach USD 1,832.0 million by 2032.

Radiation delivery systems play a central role because they determine how radiation is delivered to the tumor. Modern systems are increasingly designed to work alongside imaging technologies, treatment-planning software, and motion-management platforms.

Continuous technological development is focused on improving dose accuracy, treatment speed, patient positioning, and integration with imaging systems.

The increasing deployment of advanced linear accelerators and hybrid imaging platforms is expected to support continued demand for radiation delivery systems.

Volumetric Modulated Arc Therapy Gains Momentum

Among procedures, Volumetric Modulated Arc Therapy (VMAT) held a 36.63% market share in 2024, according to Kings Research. The segment is projected to reach USD 1,484.4 million by 2032.

VMAT allows radiation to be delivered while the treatment machine rotates around the patient. The technique can provide highly conformal radiation doses while potentially reducing treatment duration.

Its ability to precisely shape radiation around tumors makes VMAT particularly useful in modern radiation oncology.

The continued development of treatment-planning software and imaging technologies is further improving the capabilities of advanced radiation procedures. As hospitals seek efficient treatment workflows without compromising precision, demand for VMAT and other advanced techniques is expected to increase.

Breast Cancer Represents a Major Application Area

By application, the market includes breast cancer, lung cancer, prostate cancer, gastrointestinal cancers, gynecologic cancers, and other cancer types.

Breast cancer accounted for the largest application share in 2024, representing 25.42% of the market. Kings Research projects the breast cancer segment to reach USD 1,162.9 million by 2032.

The high prevalence of breast cancer and the need for precise radiation delivery are supporting demand for image-guided treatment technologies.

IGRT can help clinicians accurately position patients and target treatment areas while reducing unnecessary exposure to surrounding tissues. Imaging technologies are particularly important when treatment requires high precision around sensitive anatomical structures.

Lung, prostate, gastrointestinal, and gynecological cancers also provide significant opportunities because tumor movement and anatomical variation can create additional treatment-planning challenges.

Academic and Research Institutions Support Innovation

Hospitals remain the primary end users of IGRT systems, but academic and research institutions are becoming increasingly important for technology development.

The academic and research institutions segment is projected to grow at a CAGR of 10.24% during the forecast period.

Research centers play a critical role in evaluating advanced imaging techniques, AI-based treatment planning, adaptive radiotherapy, motion management, and emerging radiation delivery technologies.

These institutions often collaborate with technology companies and clinical organizations to test new systems and establish treatment protocols.

The growing focus on personalized oncology is likely to encourage further research into adaptive radiation therapy and AI-supported treatment decision-making.

High Capital Investment Remains a Major Challenge

Despite strong growth prospects, the high cost of IGRT equipment remains a significant barrier to adoption.

Advanced systems can require substantial investments in imaging equipment, radiation delivery platforms, facility modifications, shielding, installation, maintenance, and specialized personnel. These costs can be particularly challenging for hospitals and oncology centers operating with limited financial resources.

Kings Research identifies high capital investment and treatment costs as a major market challenge. Maintenance, calibration, software upgrades, and staff training can add to the overall cost of ownership.

Healthcare providers may therefore evaluate financing options, flexible system configurations, and technology partnerships to reduce the financial burden.

As manufacturers develop more cost-efficient systems and healthcare infrastructure expands in emerging markets, access to IGRT technologies could gradually improve.

North America Maintains Market Leadership

North America currently leads the Image Guided Radiation Therapy Market. The region accounted for 35.55% of the global market in 2024, representing approximately USD 785.7 million.

The region benefits from advanced healthcare infrastructure, strong adoption of radiation oncology technologies, high healthcare expenditure, and the presence of major medical technology companies.

Hospitals and cancer centers across the United States and Canada are increasingly adopting advanced imaging systems, MRI-guided linear accelerators, and integrated treatment-planning platforms.

In June 2024, Siemens Healthineers launched the Biograph Trinion PET/CT scanner after receiving FDA 510(k) clearance. The system combines high-resolution imaging, low-dose capabilities, and integrated PET/CT workflows, supporting the broader imaging infrastructure used in oncology.

The continued investment in precision oncology and advanced medical imaging is expected to keep North America at the forefront of the market.

Asia Pacific Emerges as the Fastest-Growing Region

Asia Pacific is expected to experience the fastest growth in the global market, with Kings Research projecting a CAGR of 10.18% from 2025 to 2032. The regional market is expected to reach approximately USD 1,420.6 million by 2032.

Growth is supported by expanding cancer treatment infrastructure, rising healthcare expenditure, increasing patient populations, and investments in advanced oncology technologies.

Healthcare providers in countries such as India, China, Japan, South Korea, and Australia are increasing their adoption of advanced radiation treatment systems.

In September 2024, Fortis Memorial Research Institute in Gurugram introduced the Elekta Unity MR-Linac, described by Kings Research as the first MRI-guided linear accelerator in North India. The system combines MRI with a linear accelerator to provide real-time imaging during treatment.

The development illustrates the growing availability of sophisticated image-guided radiation technologies across emerging healthcare markets.

Regulatory Requirements Influence Market Development

IGRT systems are highly regulated because they combine medical imaging, radiation delivery, software, and patient-specific treatment processes.

In the United States, the Food and Drug Administration (FDA) regulates radiotherapy equipment and related software as medical devices. Radiation safety is also overseen through the Nuclear Regulatory Commission and state radiation-control programs where applicable.

In Europe, IGRT systems are subject to the Medical Device Regulation (MDR 2017/745), while radiation protection requirements are addressed under the Euratom Basic Safety Standards.

China regulates radiotherapy devices through the National Medical Products Administration, while Japan applies regulatory requirements through the Pharmaceuticals and Medical Devices Agency and the country's medical-device framework.

Compliance with these requirements can increase development and commercialization timelines but is essential for ensuring the safety, reliability, and clinical effectiveness of radiation therapy technologies.

Competitive Landscape and Industry Developments

The Image Guided Radiation Therapy Market includes major medical technology companies, radiation therapy specialists, imaging companies, and software providers. Key companies identified by Kings Research include Siemens, Elekta, Accuray, ViewRay Systems, Hitachi High-Tech, Canon Medical Systems, Brainlab, Panacea Medical Technologies, Mevion Medical Systems, GE HealthCare, Philips, Toshiba, Vision RT, C-RAD, and RaySearch Laboratories.

Competition is increasingly focused on AI integration, adaptive radiotherapy, imaging quality, workflow automation, treatment planning, and real-time motion management.

In May 2025, GE HealthCare expanded its radiation oncology portfolio at ESTRO 2025, introducing AI-enabled solutions including MR Contour DL, a deep-learning model for organs-at-risk segmentation in MR images. The company also introduced an enhanced iRT software platform designed to integrate MR imaging workflows and third-party AI tools into treatment planning.

Other recent developments include Philips receiving FDA 510(k) clearance in July 2025 for an updated UroNav system for image-guided navigation in prostate cancer care. In March 2025, SkinCure Oncology submitted its GentleBeam technology to the FDA for 510(k) clearance for image-guided superficial radiation therapy.

These developments highlight the industry's movement toward more precise, software-enabled, and image-integrated treatment systems.

Future Outlook of the Image Guided Radiation Therapy Market

The future of the Image Guided Radiation Therapy Market will be shaped by AI, adaptive radiotherapy, MRI-guided treatment, advanced imaging, motion management, and personalized oncology.

Healthcare providers are expected to increasingly adopt systems capable of combining high-quality imaging with real-time radiation delivery. AI can further improve treatment workflows by automating image segmentation, identifying organs at risk, tracking tumor movement, and supporting adaptive treatment planning.

The growing use of MRI-LINAC systems is likely to remain an important trend because these platforms can provide continuous soft-tissue visualization during treatment.

Cloud-connected software and data analytics may also support treatment planning, quality assurance, workflow optimization, and collaboration between oncology specialists.

As cancer care moves toward increasingly personalized treatment strategies, IGRT will play an important role in delivering precise radiation doses while minimizing unnecessary exposure to healthy tissue.

Conclusion

The Image Guided Radiation Therapy Market is advancing rapidly as cancer treatment increasingly emphasizes precision, personalization, and improved patient outcomes. The market is projected to grow from USD 2,368.3 million in 2025 to USD 4,085.3 million by 2032, representing a CAGR of 8.10%.

The rising global cancer burden, advancements in imaging-integrated radiotherapy, AI-enhanced MRI-guided systems, adaptive treatment technologies, and growing adoption of advanced radiation delivery platforms are creating strong opportunities for market participants.

North America currently holds the largest market share, while Asia Pacific is expected to experience the fastest growth through 2032. Radiation delivery systems remain the leading product category, VMAT represents a major procedure segment, and breast cancer is the largest application area.

At the same time, high equipment costs, infrastructure requirements, specialized training, and regulatory complexity remain important challenges.

As oncology centers increasingly seek more accurate and individualized treatment approaches, image guided radiation therapy is expected to become an increasingly important component of modern cancer care. Continued innovation in AI, medical imaging, adaptive radiotherapy, and treatment-planning software will further strengthen the role of IGRT in precision radiation oncology.